Group One Trading
HOWL icon

Group One Trading’s Werewolf Therapeutics HOWL Stock Holding History

Group One Trading’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$394 – 8553
2025
Q3 		$394 Sell
200
-1,000
-83% -$1.37K ﹤0.01% 8170
2025
Q2 		$1.31K Sell
1,200
-2,500
-68% -$2.57K ﹤0.01% 7513
2025
Q1 		$3.6K Sell
3,700
-9,100
-71% -$11.9K ﹤0.01% 6780
2024
Q4 		$18.9K Buy
+12,800
New +$26.1K ﹤0.01% 5724

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Group One Trading's HOWL Position: Q2 2026 in Review

Group One Trading held its Werewolf Therapeutics (HOWL) position steady in Q2 2026 at 1,871 shares worth $673. The position accounts for ﹤0.01% of the portfolio, ranked #7245.

Group One Trading first reported a position in HOWL in Q2 2022 and has held it in 7 quarters since. The position peaked at $5.26K in Q3 2025. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

  • Group One Trading held 1,871 shares of Werewolf Therapeutics worth $673 as of Q2 2026.
  • Group One Trading left its Werewolf Therapeutics share count unchanged in Q2 2026.
  • Werewolf Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7245 holding.
  • Group One Trading first reported a position in Werewolf Therapeutics in Q2 2022 and has held it in 7 quarters since.
  • Group One Trading's Werewolf Therapeutics position peaked at $5.26K in Q3 2025.
  • 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.